Gecilmara S. Pileggi

Sao Paulo, SP 04023062, Brazil

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 49 publications

Impact of SARS-CoV-2 Vaccination on Disease Activity and Severity of COVID-19 Infection in Patients with Systemic Lupus Erythematosus: A Multicenter Cohort Study.

Impact of SARS-CoV-2 Vaccination on Disease Activity and Severity of COVID-19 Infection in Patients with Systemic Lupus Erythematosus: A Multicenter Cohort Study.

Journal: Vaccines

Published: September 07, 2025

Primary and Booster COVID-19 Vaccination in Patients with Sjögren's Disease: Data from the Longitudinal SAFER Cohort Study.

Primary and Booster COVID-19 Vaccination in Patients with Sjögren's Disease: Data from the Longitudinal SAFER Cohort Study.

Journal: Vaccines

Published: July 30, 2025

Correction: Brazilian recommendations for the management of tuberculosis infection in immune-mediated inflammatory diseases.

Correction: Brazilian recommendations for the management of tuberculosis infection in immune-mediated inflammatory diseases.

Journal: Advances in rheumatology (London, England)

Published: July 21, 2025

Reply to the letter on "Brazilian guidelines for the management of tuberculosis infection in immune-mediated inflammatory diseases: is retesting in latent tuberculosis screening appropriate and safe?"

Reply to the letter on "Brazilian guidelines for the management of tuberculosis infection in immune-mediated inflammatory diseases: is retesting in latent tuberculosis screening appropriate and safe?"

Journal: Advances in rheumatology (London, England)

Published: July 17, 2025

Immunogenicity and safety to SARS-Cov-2 vaccination in patients with systemic vasculitis.

Immunogenicity and safety to SARS-Cov-2 vaccination in patients with systemic vasculitis.

Journal: Frontiers in immunology

Published: June 28, 2025

Immunogenicity and safety of BNT162b2 vaccine in patients with juvenile immune mediated inflammatory disease.

Immunogenicity and safety of BNT162b2 vaccine in patients with juvenile immune mediated inflammatory disease.

Journal: Pediatric research

Published: June 19, 2025

Brazilian Society of Rheumatology - 2025 recommendations on vaccination in immune-mediated rheumatic diseases.

Brazilian Society of Rheumatology - 2025 recommendations on vaccination in immune-mediated rheumatic diseases.

Journal: Advances in rheumatology (London, England)

Published: June 17, 2025

Comparison of the immunogenicity and safety among COVID-19 vaccines ChadOx-1, CoronaVac and BNT162b2 in systemic lupus erythematosus (SLE) patients: a prospective cohort.

Comparison of the immunogenicity and safety among COVID-19 vaccines ChadOx-1, CoronaVac and BNT162b2 in systemic lupus erythematosus (SLE) patients: a prospective cohort.

Journal: Advances in rheumatology (London, England)

Published: December 26, 2024

Immunogenicity of SARS-CoV-2 Vaccination Schedules Including a Booster Dose in Patients with Systemic Lupus Erythematosus: Data from a Prospective Multicenter Study.

Immunogenicity of SARS-CoV-2 Vaccination Schedules Including a Booster Dose in Patients with Systemic Lupus Erythematosus: Data from a Prospective Multicenter Study.

Journal: Vaccines

Published: November 15, 2024

Immunogenicity and Safety According to Immunosuppressive Drugs and Different COVID-19 Vaccine Platforms in Immune-Mediated Disease: Data from SAFER Cohort.

Immunogenicity and Safety According to Immunosuppressive Drugs and Different COVID-19 Vaccine Platforms in Immune-Mediated Disease: Data from SAFER Cohort.

Journal: Vaccines

Published: October 29, 2024

Predictors of Hospitalization in Breakthrough COVID-19 among Fully Vaccinated Individuals with Immune-Mediated Rheumatic Diseases: Data from SAFER-Study.

Predictors of Hospitalization in Breakthrough COVID-19 among Fully Vaccinated Individuals with Immune-Mediated Rheumatic Diseases: Data from SAFER-Study.

Journal: Vaccines

Published: July 31, 2024

COVID-19 on patients with immune-mediated rheumatic disease: a comparative study of disease activity, fatigue, and psychological distress over six months.

COVID-19 on patients with immune-mediated rheumatic disease: a comparative study of disease activity, fatigue, and psychological distress over six months.

Journal: Advances in rheumatology (London, England)

Published: May 06, 2024

Showing 1-12 of 49

Last Updated: 09/26/2026